Imagin Medical announced that its contract design and development firm, Optel Inc., has delivered the functional i/BlueTM Imaging Systems that will be used to conduct in vivo studies and virtual demonstrations for evaluation by leading urologists. Two i/Blue System functional units were initially slated for a first-in-human study assessing the final product design. However, medical institutions have suspended the initiation of medical device clinical studies due to the COVID-19 pandemic. While Imagin will continue to pursue first-in-human studies when clinical trials are permitted to resume, potentially later this year, the Company is currently pursuing alternative, preclinical study options. Other i/Blue functional units will be used for virtual investor presentation and private medical demonstrations and meetings to generate interest and obtain performance feedback.